OAB-012: Early and sustained negative minimal residual disease (MRDneg) after idecabtagene vicleucel (ide-cel) defines a subset of multiple myeloma (MM) patients in KarMMa achieving prolonged survival
Clinical Lymphoma Myeloma and Leukemia(2022)
Key words
multiple myeloma,negative minimal residual disease,karmma,mrdneg,ide-cel
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined